ConductScience.org, home

Trial · NCT01837069

Risk Factor Control Before Orthopedic Surgery

NCT01837069, Phase 4, Terminated, NYU Langone Health; results first posted 2020-07-27

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Risk Factor Control Before Orthopedic Surgery. Trials, record NCT01837069. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01837069

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Risk Factor Control Before Orthopedic Surgery
NCT number
NCT01837069
Status
Terminated
Phases
Phase 4
Enrollment
198 participants, actual
Lead sponsor
NYU Langone Health
Conditions
Osteoarthritis, Cardiovascular Disease
Interventions
Metoprolol, Lisinopril, Atorvastatin, Lifestyle counseling
First posted
2013-04-22
Last updated
2020-07-27
Results first posted
2020-07-27

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumber of Partipants That Experienced Death, Myocardial Infarction, Stroke, Transient Ischemic Attack, Myocardial Necrosis, or Venous Thromboembolism30 days
SecondaryModified Composite of Cardiovascular Events30 daysthe reduction in the composite of death, myocardial infarction, stroke, transient ischemic attack, myocardial necrosis, venous thromboembolism, or reoperation
OtherLength of StayHospital stay, ~7 days
OtherEach Individual Endpoint of the Composite of Cardiovascular Events30 days

Outcomes4

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Partipants That Experienced Death, Myocardial Infarction, Stroke, Transient Ischemic Attack, Myocardial Necrosis, or Venous Thromboembolism30 daysparticipantsNUMBER
SECONDARYModified Composite of Cardiovascular Events30 daysNo data are available for this Outcome Measure. Multiple efforts were made to obtain the data from the PI but were unsuccessful, therefore, data cannot be reported.
OTHER_PRE_SPECIFIEDLength of StayHospital stay, ~7 daysdaysMEDIAN
OTHER_PRE_SPECIFIEDEach Individual Endpoint of the Composite of Cardiovascular Events30 daysEfforts were made to collect this data from PI, but data analysis was not completed for this outcome measure

Results by group4

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Partipants That Experienced Death, Myocardial Infarction, Stroke, Transient Ischemic Attack, Myocardial Necrosis, or Venous ThromboembolismTreatment10participants
Number of Partipants That Experienced Death, Myocardial Infarction, Stroke, Transient Ischemic Attack, Myocardial Necrosis, or Venous ThromboembolismControl2participants
Length of StayTreatment3Inter-Quartile Range 2 to 4days
Length of StayControl3Inter-Quartile Range 2 to 3.75days

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDTreatment103
Overall StudySTARTEDControl95
Overall StudyCOMPLETEDTreatment103
Overall StudyCOMPLETEDControl95
Overall StudyNOT COMPLETEDTreatment0
Overall StudyNOT COMPLETEDControl0

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityTreatment0103
Total, all-cause mortalityControl095
Total, other adverse eventsTreatment0103
Total, other adverse eventsControl095
Total, serious adverse eventsTreatment0103
Total, serious adverse eventsControl095

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons3

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Treatment vs Control: Number of Partipants That Experienced Death, Myocardial Infarction, Stroke, Transient Ischemic Attack, Myocardial Necrosis, or Venous ThromboembolismTrial comparisons
Treatment vs Control: deaths from any causeTrial comparisons
Treatment vs Control: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01837069

GET https://conductscience.org/api/trials/v1/NCT01837069/registered